BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

ZS Pharma 

508 Wrangler Drive
Suite 100
Coppell  Texas  75019  U.S.A.
Phone: 650-458-4100 Fax: 650-458-0084


SEARCH JOBS


Industry
Pharmaceutical






 Company News
ZS Pharma To Present Data From Phase 3 Trial Of ZS-9 In Late-Breaking Oral Presentation At National Kidney Foundation’s 2014 Spring Clinical Meetings 4/22/2014 6:51:18 AM    More...
ZS Pharma To Present Results Of Phase 2 Trial Of ZS-9 At 2014 American College of Cardiology’s Annual Scientific Session 3/27/2014 9:44:23 AM    More...
ZS Pharma Announces Start Of Enrollment Of Phase 3 Extended Dosing Study Of ZS-9 In Patients With Hyperkalemia 3/25/2014 9:43:20 AM    More...
Texas Biotech ZS Pharma Secures $55 Million To Develop Kidney Drug 3/6/2014 7:01:53 AM    More...
ZS Pharma Announces Positive Results From The Extended Treatment Phase Of Its Phase 3 Trial Of ZS-9 In Patients With Hyperkalemia 1/13/2014 11:14:32 AM    More...
ZS Pharma To Present At J.P. Morgan Healthcare Conference 1/9/2014 7:29:26 AM    More...
LifeSci Advisors Initiates Coverage Of ZS Pharma 1/8/2014 9:58:39 AM    More...
ZS Pharma Announces Positive Top-Line Results of Phase 3 Trial of ZS-9 in Patients With Hyperkalemia 11/10/2013 12:33:13 AM    More...
ZS Pharma Completes Patient Enrollment in Pivotal Phase 3 Clinical Trial Evaluating ZS-9 for the Treatment of Hyperkalemia 10/23/2013 10:16:59 AM    More...
ZS Pharma Appoints Todd A. Creech as Chief Financial Officer 10/15/2013 6:16:45 AM    More...
12

//-->